NO996572L - Nye substituerte imidazolforbindelser - Google Patents

Nye substituerte imidazolforbindelser

Info

Publication number: NO996572L
Authority: NO; Norway
Prior art keywords: imidazole compounds; substituted imidazole; new substituted; new; compounds
Prior art date: 1997-07-02

Application number

NO996572A

Other languages

English (en)

Other versions

NO996572D0 (no

Inventor

Jerry L Adams

Ralph Floyd Hall

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-02

Filing date

1999-12-30

Publication date

1999-12-30

1999-12-30 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1999-12-30 Publication of NO996572L publication Critical patent/NO996572L/no

1999-12-30 Publication of NO996572D0 publication Critical patent/NO996572D0/no

Links

150000002460 imidazoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)

NO996572A 1997-07-02 1999-12-30 Nye substituerte imidazolforbindelser NO996572D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5159297P	1997-07-02	1997-07-02
PCT/US1998/013809 WO1999001130A1 (en)	1997-07-02	1998-07-01	Novel substituted imidazole compounds

Publications (2)

Publication Number	Publication Date
NO996572L true NO996572L (no)	1999-12-30
NO996572D0 NO996572D0 (no)	1999-12-30

Family

ID=21972242

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996572A NO996572D0 (no)	1997-07-02	1999-12-30	Nye substituerte imidazolforbindelser

Country Status (22)

Country	Link
EP (2)	EP0996446B1 (no)
JP (2)	JP2002507992A (no)
KR (1)	KR20010014420A (no)
CN (1)	CN1134420C (no)
AR (1)	AR016294A1 (no)
AT (1)	ATE290001T1 (no)
AU (1)	AU8381298A (no)
BR (1)	BR9810342A (no)
CA (2)	CA2294522A1 (no)
CO (1)	CO4950624A1 (no)
CZ (1)	CZ9904750A3 (no)
DE (2)	DE69829192T2 (no)
ES (2)	ES2237843T3 (no)
HU (1)	HUP0002050A3 (no)
IL (3)	IL133035A0 (no)
NO (1)	NO996572D0 (no)
NZ (1)	NZ500922A (no)
PL (1)	PL337738A1 (no)
TR (1)	TR200000014T2 (no)
TW (1)	TW536539B (no)
WO (2)	WO1999001131A1 (no)
ZA (1)	ZA985763B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
US6087381A (en)	1997-05-22	2000-07-11	G. D. Searle & Company	Pyrazole derivatives as p38 kinase inhibitors
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
US20020156104A1 (en)	1997-06-13	2002-10-24	Jerry L. Adams	Novel pyrazole and pyrazoline substituted compounds
JP2002505690A (ja)	1997-06-19	2002-02-19	スミスクライン・ビーチャム・コーポレイション	新規なアリールオキシピリミジン置換イミダゾール化合物
GB9713726D0 (en)	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
US6362193B1 (en)	1997-10-08	2002-03-26	Smithkline Beecham Corporation	Cycloalkenyl substituted compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
ES2221426T3 (es)	1998-08-20	2004-12-16	Smithkline Beecham Corporation	Nuevos compuestos de triazol sustituidos.
US6548503B1 (en)	1998-11-04	2003-04-15	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
JP2003514900A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
ES2230171T3 (es)	1999-11-23	2005-05-01	Smithkline Beecham Corporation	Compuestos 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p38 quinasa.
DE60023025T2 (de)	1999-11-23	2006-07-13	Smithkline Beecham Corp.	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
CO5261556A1 (es)	1999-12-08	2003-03-31	Pharmacia Corp	Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
AR038957A1 (es)	2001-08-15	2005-02-02	Pharmacia Corp	Terapia de combinacion para el tratamiento del cancer
US20030225089A1 (en) *	2002-04-10	2003-12-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
AU2003245989A1 (en) *	2002-07-09	2004-01-23	Boehringer Ingelheim Pharma Gmbh And Co. Kg	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
ES2350977T3 (es)	2002-11-05	2011-01-28	Glaxo Group Limited	Agentes antibacterianos.
JP2007516258A (ja)	2003-12-12	2007-06-21	ワイス	心臓血管の疾患治療に有用なキノリン誘導体
TWI332003B (en) *	2004-01-30	2010-10-21	Lilly Co Eli	Kinase inhibitors
MXPA06012512A (es) *	2004-04-28	2007-02-08	Tanabe Seiyaku Co	Compuesto heterociclico.
MY143245A (en) *	2004-04-28	2011-04-15	Mitsubishi Tanabe Pharma Corp	4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
WO2006062110A1 (ja) *	2004-12-06	2006-06-15	Banyu Pharmaceutical Co., Ltd.	ピペラジン誘導体
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
JP5324785B2 (ja)	2005-10-28	2013-10-23	武田薬品工業株式会社	複素環アミド化合物及びその用途
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
BR112015010109A2 (pt) *	2012-11-05	2017-07-11	Nant Holdings Ip Llc	derivados de indol-5-ol substituídos e suas aplicações terapêuticas
ES2927715T3 (es)	2017-10-05	2022-11-10	Fulcrum Therapeutics Inc	Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD
CA3159239A1 (en) *	2019-11-29	2021-06-03	Pui Leng Loke	Novel compounds for treatment of diseases related to dux4 expression
WO2021105474A1 (en) *	2019-11-29	2021-06-03	Facio Intellectual Property B.V.	New compounds for treatment of diseases related to dux4 expression

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ188244A (en) *	1977-09-13	1981-04-24	Ici Australia Ltd	2-substituted pyrimidines compositions growth regulating processes
GR75287B (no) *	1980-07-25	1984-07-13	Ciba Geigy Ag
US4503065A (en) *	1982-08-03	1985-03-05	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
US4725600A (en) *	1984-07-13	1988-02-16	Fujisawa Pharmaceutical Co., Ltd.	Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH082883B2 (ja) *	1986-06-06	1996-01-17	クミアイ化学工業株式会社	２−フエノキシピリミジン誘導体および除草剤
IL83467A0 (en) *	1986-08-15	1988-01-31	Fujisawa Pharmaceutical Co	Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5593991A (en) *	1993-07-16	1997-01-14	Adams; Jerry L.	Imidazole compounds, use and process of making
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
PL321292A1 (en) *	1995-01-12	1997-11-24	Smithkline Beecham Corp	Novel xchemical compounds
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US5756499A (en) *	1996-01-11	1998-05-26	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1005343A4 (en) *	1996-03-08	2000-06-07	Smithkline Beecham Corp	USE OF CSAIDS AS ANGIOGENESIS INHIBITORS
WO1997035856A1 (en) *	1996-03-25	1997-10-02	Smithkline Beecham Corporation	Novel treatment for cns injuries

1998
- 1998-06-30 AR ARP980103180A patent/AR016294A1/es not_active Application Discontinuation
- 1998-07-01 CZ CZ19994750A patent/CZ9904750A3/cs unknown
- 1998-07-01 EP EP98934244A patent/EP0996446B1/en not_active Expired - Lifetime
- 1998-07-01 ES ES98934247T patent/ES2237843T3/es not_active Expired - Lifetime
- 1998-07-01 ZA ZA985763A patent/ZA985763B/xx unknown
- 1998-07-01 CO CO98037026A patent/CO4950624A1/es unknown
- 1998-07-01 HU HU0002050A patent/HUP0002050A3/hu active IP Right Revival
- 1998-07-01 BR BR9810342-3A patent/BR9810342A/pt not_active Application Discontinuation
- 1998-07-01 JP JP50738599A patent/JP2002507992A/ja active Pending
- 1998-07-01 ES ES98934244T patent/ES2207847T3/es not_active Expired - Lifetime
- 1998-07-01 WO PCT/US1998/013805 patent/WO1999001131A1/en not_active Ceased
- 1998-07-01 AU AU83812/98A patent/AU8381298A/en not_active Abandoned
- 1998-07-01 CA CA002294522A patent/CA2294522A1/en not_active Abandoned
- 1998-07-01 KR KR1019997012604A patent/KR20010014420A/ko not_active Ceased
- 1998-07-01 DE DE69829192T patent/DE69829192T2/de not_active Expired - Fee Related
- 1998-07-01 AT AT98934247T patent/ATE290001T1/de not_active IP Right Cessation
- 1998-07-01 NZ NZ500922A patent/NZ500922A/en unknown
- 1998-07-01 PL PL98337738A patent/PL337738A1/xx unknown
- 1998-07-01 WO PCT/US1998/013809 patent/WO1999001130A1/en not_active Ceased
- 1998-07-01 TR TR2000/00014T patent/TR200000014T2/xx unknown
- 1998-07-01 IL IL13303598A patent/IL133035A0/xx unknown
- 1998-07-01 EP EP98934247A patent/EP1014976B1/en not_active Expired - Lifetime
- 1998-07-01 CA CA002294524A patent/CA2294524A1/en not_active Abandoned
- 1998-07-01 JP JP50738999A patent/JP2002507994A/ja active Pending
- 1998-07-01 CN CNB988066440A patent/CN1134420C/zh not_active Expired - Fee Related
- 1998-07-01 DE DE69818266T patent/DE69818266T2/de not_active Expired - Fee Related
- 1998-08-27 TW TW087110613A patent/TW536539B/zh not_active IP Right Cessation
1999
- 1999-12-30 NO NO996572A patent/NO996572D0/no not_active Application Discontinuation
2008
- 2008-03-17 IL IL190216A patent/IL190216A0/en unknown
- 2008-03-17 IL IL190215A patent/IL190215A0/en unknown

Also Published As

Publication number	Publication date
AU737637B2 (en)	2001-08-23
CN1261277A (zh)	2000-07-26
JP2002507992A (ja)	2002-03-12
EP0996446B1 (en)	2003-09-17
TW536539B (en)	2003-06-11
BR9810342A (pt)	2000-09-05
KR20010014420A (ko)	2001-02-26
EP1014976A4 (en)	2001-08-29
DE69818266D1 (de)	2003-10-23
IL190215A0 (en)	2008-11-03
CA2294522A1 (en)	1999-01-14
DE69818266T2 (de)	2004-07-15
DE69829192D1 (de)	2005-04-07
ES2207847T3 (es)	2004-06-01
HUP0002050A3 (en)	2002-04-29
ATE290001T1 (de)	2005-03-15
TR200000014T2 (tr)	2000-11-21
AU8381598A (en)	1999-01-25
CO4950624A1 (es)	2000-09-01
DE69829192T2 (de)	2006-02-16
WO1999001131A1 (en)	1999-01-14
CZ9904750A3 (cs)	2001-12-12
NZ500922A (en)	2001-12-21
CN1134420C (zh)	2004-01-14
WO1999001130A1 (en)	1999-01-14
IL190216A0 (en)	2008-11-03
EP0996446A1 (en)	2000-05-03
IL133035A0 (en)	2001-03-19
AR016294A1 (es)	2001-07-04
EP0996446A4 (en)	2001-08-29
CA2294524A1 (en)	1999-01-14
NO996572D0 (no)	1999-12-30
AU8381298A (en)	1999-01-25
ZA985763B (en)	1999-01-19
HUP0002050A2 (hu)	2001-04-28
JP2002507994A (ja)	2002-03-12
EP1014976A1 (en)	2000-07-05
EP1014976B1 (en)	2005-03-02
PL337738A1 (en)	2000-08-28
ES2237843T3 (es)	2005-08-01

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO996572D0 (no)	1999-12-30	Nye substituerte imidazolforbindelser
NO983181L (no)	1998-09-10	Nye substituerte imidazolforbindelser
NO20000226D0 (no)	2000-01-17	Nye spiroazabicykliske heterocykliske forbindelser
NO20005878L (no)	2000-11-21	Nye 2-alkylsubstituerte imidazolforbindelser
IS5354A (is)	2000-01-20	Ný efnasambönd
BR9612465A (pt)	1999-07-13	Compostos heterocíclicos
DK0861235T3 (da)	2001-12-27	Substituerede benzylaminopiperidinforbindelser
ID18759A (id)	1998-05-07	Imidazole tersubstitusi sikloalkil baru
ID19609A (id)	1998-07-23	Senyawa-senyawa heterosiklik
NO20001938D0 (no)	2000-04-13	Nye aryloksy-alkyl-dialkylaminer
ID18685A (id)	1998-04-30	Senyawa trisiklik tersubstitusi
NO974605D0 (no)	1997-10-06	Nye heterosykliske forbindelser
FI973207A7 (fi)	1997-10-01	Heterosyklisiä yhdisteitä
NO981216L (no)	1998-03-18	Nye heterosykliske forbindelser
ID22983A (id)	1999-12-23	Senyawa-senyawa fluorometoksimino
EE9900466A (et)	2000-04-17	Ühendid
NO995430D0 (no)	1999-11-05	Nye heterosykliske forbindelser
NO994838L (no)	1999-11-30	<pi>-kompleks-forbindelser
DK0851865T3 (da)	2002-10-14	Hidtil ukendte heterocykliske forbindelser
SE9702535D0 (sv)	1997-07-01	New compounds
SE9704839D0 (sv)	1997-12-22	New compounds
SE9703225D0 (sv)	1997-09-08	new compounds
SE9702696D0 (sv)	1997-07-14	New compounds
SE9702378D0 (sv)	1997-06-19	New compounds
SE9702747D0 (sv)	1997-07-18	New compounds